RPHM NASDAQ
Reneo Pharmaceuticals, Inc.
1W: +9.6%
1M: +27.3%
3M: +23.8%
1Y: -75.2%
3Y: -74.8%
$18.20
Last traded 2024-10-04 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+100.0% YoY
$-15M
Net Income
-145.6% YoY
$-48M
Free Cash Flow
-44.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-12.3%
ROA-11.6%
ROIC1464.5%
Valuation
P/E-5.2
P/B5.3
EV/EBITDA-23.9
Leverage
Debt/Equity0.01
Current Ratio26.75
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z74.40
Beneish M0.00